TABLE 3.
Univariate analysis of lymph node positivity.
| Lymoh node positivity, n (%) | Univariable analysis | |||
|---|---|---|---|---|
| Odds ratio | 95% Cl for odds ratio | p value | ||
| Pathological type | 0.941 | |||
| IDC | 224/555 (40.4) | Referent | ||
| ILC | 5/11 (45.5) | 1.231 | 0.371–4.084 | 0.734 |
| Other | 16/39 (41.0) | 1.028 | 0.531–1.989 | 0.935 |
| Lymphovascular/perineural invasion | ||||
| (−) | 158/478 (33.1) | Referent | ||
| (+) | 105/127 (82.7) | 4.405 | 2.894–6.705 | <0.001 |
| Histological grade | ||||
| I–II | 81/245 (33.1) | Referent | ||
| III | 160/338 (47.3) | 1.809 | 1.285–2.545 | 0.001 |
| Tmax stage (using the largest tumor diameter) | <0.001 | |||
| T1 | 88/305 (28.9) | Referent | ||
| T2 | 146/279 (52.3) | 2.512 | 1.788–3.529 | <0.001 |
| T3 | 11/21 (52.4) | 3.185 | 1.297–7.823 | 0.012 |
| Tsum stage(using the aggregate tumor diameter) | <0.001 | |||
| T1 | 65/259 (25.1) | Referent | ||
| T2 | 155/308 (50.3) | 3.103 | 2.167–4.443 | <0.001 |
| T3 | 25/38 (65.8) | 4.576 | 2.253–9.295 | <0.001 |
| Multiplicity | ||||
| UF | 180/484 (37.2) | Referent | ||
| MF/MC | 65/121 (53.7) | 1.960 | 1.311–2.931 | 0.001 |